DF
DGX icon

DecisionPoint Financial’s Quest Diagnostics DGX Stock Holding History

DecisionPoint Financial’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$649 Sell
3
-12
-80% -$2.35K ﹤0.01% 549
2026
Q1 		$2.94K Hold
15
– – ﹤0.01% 257
2025
Q4 		$2.6K Hold
15
– – ﹤0.01% 308
2025
Q3 		$2.73K Hold
15
– – ﹤0.01% 216
2025
Q2 		$2.69K Buy
+15
New +$2.6K ﹤0.01% 215

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

DecisionPoint Financial's DGX Position: Q2 2026 in Review

DecisionPoint Financial reduced its Quest Diagnostics (DGX) stake by 80% in Q2 2026, selling an estimated $2.35K and leaving 3 shares worth $649. The position accounts for ﹤0.01% of the portfolio, ranked #549.

DecisionPoint Financial first reported a position in DGX in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.94K in Q1 2026. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • DecisionPoint Financial held 3 shares of Quest Diagnostics worth $649 as of Q2 2026.
  • DecisionPoint Financial sold 12 Quest Diagnostics shares in Q2 2026, an estimated $2.35K.
  • Quest Diagnostics made up ﹤0.01% of DecisionPoint Financial's portfolio in Q2 2026, its #549 holding.
  • DecisionPoint Financial first reported a position in Quest Diagnostics in Q2 2025 and has held it in 5 quarters since.
  • DecisionPoint Financial's Quest Diagnostics position peaked at $2.94K in Q1 2026.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on DecisionPoint Financial's 13F filing for Q2 2026, filed 5 Aug 2026.